https://www.news-medical.net/news/20230103/Phase-III-trial-shows-noninferiority-of-VV116-compared-to-nirmatrelvire28093ritonavir-among-adults-with-mild-to-moderate-COVID-19-at-risk-of-progression.aspx
0
0
Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression - News-Medical.Net
+ 44 more
1/3/23 at 12:15pm
Organization
News-Medical.Net
Authors
Details
44 words
Summarize
general noninferiority VV116 anti-SARS-CoV-2
Researchers presented the results of a phase III randomized controlled trial of oral SARS-CoV-2 antiviral VV116.
Create an account or login to join the discussion